White label ELPA - ClinicalTrials.eu

Study on the Effects of Oral Lidocaine (ORE-001) on Food Intake in Underweight Elderly Patients

Recruiting

2 1
Investigated diseases:
- Underweight
Investigated drugs:
- Lidocaine Hydrochloride Monohydrate
Study on Bumetanide for Improving Cognitive Function in Children and Adolescents with Down Syndrome

Recruiting

2 1 1
Investigated diseases:
- Trisomy 21
Investigated drugs:
- BUMETANIDE
Study on Stopping Nivolumab or Pembrolizumab in Advanced Melanoma Patients After Achieving a Response

Recruiting

3 1 1 1
Investigated diseases:
- Malignant melanoma
Investigated drugs:
- Nivolumab
- Pembrolizumab
Study on How Exenatide Affects Early Parkinson’s Disease Progression in Patients

Recruiting

2 1 1
Investigated diseases:
- Parkinson’s disease
Investigated drugs:
- Exenatide
Study Comparing Intrathecal Morphine and TAP Block with Ropivacaine and Clonidine for Pain Relief in Patients Undergoing Elective Cesarean Section

Recruiting

3 1 1 1
Investigated diseases:
- Caesarean section
Investigated drugs:
- Clonidine Hydrochloride
- Ropivacaine Hydrochloride
Study on the Effects of Cholecalciferol and Glycerol on Inflammation in Obese Elderly Patients with Vitamin D Deficiency

Recruiting

3 1 1
Investigated diseases:
- Obesity
Investigated drugs:
- Colecalciferol
- Glycerol
Study on the Safety of Rotigotine for Patients with Autosomal Dominant Polycystic Kidney Disease

Recruiting

2 1 1 1
Investigated diseases:
- Congenital cystic kidney disease
Investigated drugs:
- Rotigotine
Study of Dostarlimab for Patients with Untreated Stage III Resectable Colon Cancer

Recruiting

2 1 1 1
Investigated diseases:
- Colon cancer
Investigated drugs:
- Dostarlimab
Study of PF-06821497 and Enzalutamide for Men with Advanced Prostate Cancer Resistant to Hormone Therapy

Recruiting

3 1 1
Investigated diseases:
- Hormone-refractory prostate cancer
- Prostate cancer metastatic
Investigated drugs:
- 5,8-Dichloro-2-[(4-Methoxy-6-Methyl-2-Oxo-1,2-Dihydropyridin-3-Yl)Methyl]-7-[(R)-Methoxy(Oxetan-3-Yl)Methyl]-3,4-Dihydroisoquinolin-1(2H)-One
- Enzalutamide
+8
Study on the Effects of Tumor Removal in Patients with Metastatic Kidney Cancer Treated with Nivolumab and Ipilimumab Combination

Recruiting

3 1 1 1
Investigated diseases:
- Metastatic renal cell carcinoma
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies